Anavex Life Sciences Corp. (AVXL)
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimers Disease
Sensei Biotherapeutics Inc (SNSE)
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
Twist Bioscience (TWST)
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
Cidara Therapeutics Inc. (CDTX)
Merck to Acquire Cidara Therapeutics, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
Castle Biosciences Inc (CSTL)
Castle Biosciences - New Data Confirms Performance ofDecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
Bristol-Myers Squibb Company (BMY)
Bristol Myers Squibb - Update on Phase 3 Librexia ACS Trial
SATELLOS BIOSCIENCE INC. (MSCLF)
Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
Castle Biosciences Inc (CSTL)
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
Ionis Pharmaceuticals Inc (IONS)
DAWNZERA™ (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE)
Marker Therapeutics Inc. (MRKR)
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates